Latest News for: biotech

Edit

Biotech firm’s ballot measure would make Nevada a testing ground

Image Elko Daily Free Press 12 Feb 2026
LAS VEGAS — A Las Vegas-based biotech CEO has a vision of Nevada as a hub for medical innovation. And he is hoping voters will help him make it happen ... .
Edit

Kane Biotech Restarts Commercial Activities and Strengthens North American Management

Nasdaq Globe Newswire 12 Feb 2026
Company enters 2026 with renewed business momentum and key commercial appointments in the U.S. and Canada. Company enters 2026 with renewed business momentum and key commercial appointments in the U.S. and Canada ... .
Edit

From stablecoins to biotech: Why YZi Labs is betting on things that haven't happened yet

CoinDesk 12 Feb 2026
Ella Zhang of YZi Labs says her firm invests in founders building what doesn’t yet exist, guided by first principles and long-term conviction across AI, biotech and Web3 ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Krystal Biotech Inc)

Public Technologies 12 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... 2 ... Krystal Biotech, Inc ... C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701 3 ... C/O KRYSTAL BIOTECH, INC ... Krystal Biotech Inc.
Edit

CNM Biotech program provides direct pipeline to UNM (The University of New Mexico)

Public Technologies 12 Feb 2026
"The lab was so impressed with my work that they gave me a job offer, and I was more than happy to accept and because of my skills I learned from biotech I was able to jump right in seamlessly," Pena said.
Edit

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses ...

Nasdaq Globe Newswire 12 Feb 2026
12, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd ... Parallel to its clinical successes, Jyong Biotech has executed on its strategy to monetize its pipeline through regional co-commercialization.
Edit

January 2026 Factsheet (The Biotech Growth Trust plc)

Public Technologies 12 Feb 2026
The Biotech Growth Trust PLC (the "Company") seeks capital appreciation through investment in the worldwide biotechnology industry ... Krystal Biotech ... Biotech Growth (Price) NASDAQ Biotechnology Index (net, total return, sterling adjusted).
Edit

Year-end Report Q4 2025 (Active Biotech AB)

Public Technologies 12 Feb 2026
ACTIVE BIOTECH AB ... Active Biotech announced that preclinical data of tasquinimod in combination with T cell activation will be presented at ASH 2025 (November 3) ... Active Biotech AB (Corp ... About Active Biotech Active Biotech AB (publ) (NASDAQ Stockholm.
Edit

Fragile X Syndrome Market to Grow at ~7% CAGR Through 2034 Across 7MM, with 122,000 ...

GetNews 12 Feb 2026
"Fragile X Syndrome Market". Leading companies in the Fragile X syndrome space include Zynerba Pharmaceuticals, Confluence Pharmaceuticals, Tetra Therapeutics, Neuren Pharmaceuticals, Healx, Nova Mentis Life Science, and others ... Healx Gaboxadol ... Email.
Edit

New Book Uncovers the Hidden Root of Chronic Fatigue, POTS, and Dysautonomia Retired Chiropractor John ...

GetNews 12 Feb 2026
of individuals suffer from chronic fatigue, postural orthostatic tachycardia syndrome (POTS), and dysautonomia—often without clear answers or lasting relief. In his new book, The Hidden Epidemic ... Herbert ... Key topics covered in the book include..
Edit

The Science of Sharper Thinking: Sustainable Ways to Support Memory and Mental Performance

GetNews 12 Feb 2026
In an economy powered by ideas, clarity of thought is a competitive edge. The ability to retain information, connect patterns, recall details, and stay focused under pressure influences everything from leadership decisions to academic achievement ... ....
Edit

Degenerative Disc Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by ...

GetNews 12 Feb 2026
The Degenerative Disc Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase ... In September 2024, Spine BioPharma Inc ... Stay ahead in ... SB-01 ... 1.
Edit

Diabetic Foot Ulcers Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight ...

GetNews 12 Feb 2026
In November 2025, Kane Biotech Inc ... Transwell Biotech ... Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and others.
Edit

Psychotherapist G.Roy Bristol Challenges the Concept of Freedom in New Release, “Mentally Incarcerated”

GetNews 12 Feb 2026
says “We live in a world where many are functional and productive yet remain internally confined by unexamined fears and inherited beliefs”. G.Roy Bristol is an experienced psychotherapist with a clinical practice of more than 20 years ... MA.
Edit

Atopic Dermatitis Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Kymab, BiomX, ...

GetNews 12 Feb 2026
Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB ... Oneness Biotech.

Article Search

tools
×
×
×
×